Key result
Symptom self-management via headset or face-to-face improves relaxation, stress, and knowledge in post-AMI inpatients.
Why the study?
Acute myocardial infarction is a leading cause of morbidity and mortality worldwide, motivating an evaluation of a newly developed symptom self-management program on health outcomes among post-AMI inpatients.
Does a symptom self-management program delivered via headset or face-to-face improve relaxation, stress, and knowledge in adult inpatients post-acute myocardial infarction?
RCT (n=90)
randomly assigned
No
Does a symptom self-management program delivered via headset or face-to-face improve relaxation, stress, and knowledge in adult inpatients post-acute myocardial infarction?
Effect estimate: ηp2 0.11 (relaxation), 0.14 (objective stress), 0.62 (knowledge)
A symptom self-management program delivered via headset or face-to-face significantly improved relaxation, objective stress, and knowledge in post-AMI inpatients, suggesting potential utility in cardiac rehabilitation.
Supports incorporating symptom self-management into post-AMI inpatient care; extends evidence for headset or in-person delivery in cardiac rehabilitation.
Acute myocardial infarction (AMI) is a leading cause of morbidity and mortality worldwide. This study aimed to test the efficacy of a newly-developed symptom self-management program on health outcomes among inpatients post-AMI. A pilot randomised, controlled trial was utilised. A convenience sample of 90 was recruited from a tertiary hospital in Singapore. Adult inpatients with post-AMI were randomly assigned to the three groups: IManage-HSet, IManage-FF or control group. Sample size was computed using power analysis. Data were collected through self-reported questionnaires and physiological instruments. Data analyses included univariate statistics, analysis of variance and repeated measure analysis of variance. Ninety participants were recruited with 30 in each group. Participants in the IManage-HSet and IManage-FF group had significantly greater relaxation (ηp2 = 0.11), lower objective stress (ηp2 =0.14), and greater knowledge (ηp2 = 0.62) than those of the control group. The two intervention groups had lower subjective stress (ηp2 = 0.04), depression (ηp2 = 0.01), and anxiety (ηp2 = 0.03) than the control but such differences did not achieve statistical significance. Furthermore, most participants reported that they were satisfied with the programs and they provided positive comments on the contents, educational materials and relaxation practice. This pilot study supports the potential benefits and feasibility of the IManage-VR and IManage-FF interventions on stress, perceived relaxation, knowledge and patient satisfaction. Contents of the symptom management interventions could be added into current cardiac rehabilitation programs. Future RCTs with multi-centered sites and larger sample size are required to further test the intervention. This study was prospectively registered with the International Standard Randomised Controlled Trial on the 5th August 2014 with registration number ISRCTN61027816.
No takes yet. Share an insight, caveat, or question.
Klainin‐Yobas et al. (2023) conducted an RCT in Acute myocardial infarction (n=90). Symptom self-management program (IManage-HSet and IManage-FF) vs. Control group was evaluated on Relaxation, objective stress, and knowledge (ηp2 0.11 (relaxation), 0.14 (objective stress), 0.62 (knowledge)). A symptom self-management program delivered via headset or face-to-face significantly improved relaxation (ηp2=0.11), objective stress (ηp2=0.14), and knowledge (ηp2=0.62) in post-AMI inpatients.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: